Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems.

Sophia Marie-Therese SchmitzAndreas KrohTom Florian UlmerJulia AndruszkowTom LueddeJonathan Frederik BrozatUlf Peter NeumannPatrick Hamid Alizai

Published in: BMC gastroenterology (2020)

APRI allows screening of NAFLD as well as fibrosis in obese patients. This score is easy to calculate and affordable, while conveniently only using routine clinical parameters. Using the NAS histologic scoring system bears the risk of underdiagnosing NASH in comparison to SAF score.

Keyphrases

obese patients
bariatric surgery
gastric bypass
roux en y gastric bypass
weight loss